Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
September 24, 2004
Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus
Helmut B Gottlieb, Kurt J Varner, Velga A Kenigs, et al.
Journal of Experimental Psychology. General
|
June 1, 1997
Emotion, motivation, and text comprehension: the detection of contradictions in passages
H C Ellis, S A Ottaway, L J Varner, et al.
Cardiovascular Toxicology
|
April 11, 2025
AhR Activation at the Air-Blood Barrier Alters Systemic microRNA Release After Inhalation of Particulate Matter Containing Environmentally Persistent Free Radicals
Ankit Aryal, Ashlyn C Harmon, Alexandra Noël, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Role of renal nerves in experimental hypertension: evaluation of neurogenic mechanisms
C P Barrés, S J Lewis, C L Grosskreutz, et al.
Cardiovascular Research
|
February 9, 2010
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction
Kevin C Lord, Sylvia K Shenouda, Elizabeth McIlwain, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy
Lisa A Badon, Alissa Hicks, Kevin Lord, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 4, 2012
Environmentally persistent free radicals decrease cardiac function and increase pulmonary artery pressure
Sarah Mahne, Gin C Chuang, Edward Pankey, et al.
Drug and Alcohol Dependence
|
October 24, 2001
Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity
K J Varner, N D Hein, B A Ogden, et al.
Psychopharmacology
|
September 14, 2012
Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats
Kurt J Varner, Kyle Daigle, Peter F Weed, et al.
Peptides
|
July 20, 2017
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice
Venkat Subramaniam, Gin Chuang, Huijing Xia, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
The Journal of Pharmacology and Experimental Therapeutics
|
September 24, 2004
Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus
Helmut B Gottlieb, Kurt J Varner, Velga A Kenigs, et al.
Journal of Experimental Psychology. General
|
June 1, 1997
Emotion, motivation, and text comprehension: the detection of contradictions in passages
H C Ellis, S A Ottaway, L J Varner, et al.
Cardiovascular Toxicology
|
April 11, 2025
AhR Activation at the Air-Blood Barrier Alters Systemic microRNA Release After Inhalation of Particulate Matter Containing Environmentally Persistent Free Radicals
Ankit Aryal, Ashlyn C Harmon, Alexandra Noël, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Role of renal nerves in experimental hypertension: evaluation of neurogenic mechanisms
C P Barrés, S J Lewis, C L Grosskreutz, et al.
Cardiovascular Research
|
February 9, 2010
Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction
Kevin C Lord, Sylvia K Shenouda, Elizabeth McIlwain, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy
Lisa A Badon, Alissa Hicks, Kevin Lord, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 4, 2012
Environmentally persistent free radicals decrease cardiac function and increase pulmonary artery pressure
Sarah Mahne, Gin C Chuang, Edward Pankey, et al.
Drug and Alcohol Dependence
|
October 24, 2001
Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity
K J Varner, N D Hein, B A Ogden, et al.
Psychopharmacology
|
September 14, 2012
Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats
Kurt J Varner, Kyle Daigle, Peter F Weed, et al.
Peptides
|
July 20, 2017
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice
Venkat Subramaniam, Gin Chuang, Huijing Xia, et al.
Page
of 7